The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Clinical Trials
Food Science & Nutrition · 2025-06 · 13 (6)
DOI: 10.1002/fsn3.70423 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Food Science & Nutrition, online erschienen am 12.06.2025. Verfasst von Ali Jafari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute Shahi…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study aimed to assess the impact of Ganoderma lucidum supplementation (200–11,200 mg/day, 1–24 weeks) on health‐related indices in populations including healthy, at‐risk, and chronic disease individuals. A systematic review and meta‐analysis were conducted using data from EMBASE, PubMed, Web of Science, and Scopus up to August 2024. Pooled analysis of 17 randomized controlled trials (RCTs) involving 971 participants revealed that Ganoderma lucidum supplementation demonstrated significant reductions in body mass index (BMI) (Weighted Mean Difference [WMD] = −0.43; 95% Confidence Interval [CI]: −0.77, −0.10; p = 0.011), creatinine (WMD = −0.14; 95% CI: −0.27, −0.02; p = 0.028), glutathione peroxidase (GPx) (WMD = 2.29; 95% CI: 1.67, 2.92; p < 0.001), and heart rate (HR) (WMD = −3.92; 95% CI: −7.45, −0.40; p = 0.029). No significant effects were observed on body fat, waist circumference, blood pressure, fasting glucose, lipid profile, inflammatory markers, or liver enzymes. Subgroup analyses indicated effects varied by health condition, dosage, duration, and age. Subgroup analyses revealed variations in the effects of Ganoderma supplementation based on health conditions, dosage, intervention duration, age at intervention, country, sample size, and publication year. Significant improvements were observed in BMI, TC, creatinine, and MDA in specific subgroups, such as those receiving lower doses (< 1400 mg/day) or those aged < 50 years. The GRADE profile for Ganoderma supplementation evaluated the certainty of the outcomes and indicated that the quality of evidence was very low across all outcomes. Ganoderma lucidum supplementation may have modest effects on certain health indices, but the evidence is limited by very low quality.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute Shahid Beheshti University of Medical Sciences Tehran Iran.
- Systematic Review and Meta-Analysis Expert Group (SRMEG) Universal Scientific Education and Research Network (USERN) Tehran Iran.
- Department of Nutrition, School of Nutritional Sciences and Dietetics Tehran University of Medical Sciences (TUMS) Tehran Iran.
- Semnan University of Medical Sciences Semnan Iran.
- Department of Basic Medical Sciences, School of Medicine Abadan University of Medical Sciences Abadan Iran.
ORCID-Profile: Bahareh Arghavan
Zitieren
APA
Jafari, A., Mardani, H., Mirzaei Fashtali, Z., & Arghavan, B. (2025). The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Clinical Trials. Food Science & Nutrition, 13(6). https://doi.org/10.1002/fsn3.70423
Vancouver
Jafari A, Mardani H, Mirzaei Fashtali Z, Arghavan B. The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Clinical Trials. Food Science & Nutrition. 2025;13(6). doi:10.1002/fsn3.70423
BibTeX
@article{Jafari2025,
author = {Jafari, Ali and Mardani, Helia and Mirzaei Fashtali, Zahra and Arghavan, Bahareh},
title = {The Nutritional Significance of Ganoderma lucidum on Human Health: A GRADE ‐Assessed Systematic Review and Meta‐Analysis of Clinical Trials},
journal = {Food Science & Nutrition},
year = {2025},
volume = {13},
number = {6},
doi = {10.1002/fsn3.70423}
}
EUVIMED